T3 Blood Levels and Treatment Outcome in Depression

Abstract

Objective:

We examined the correlation between the basal triiodothyronine resin uptake (T₃-RU) levels in depressed subjects and the response to antidepressant treatment.

Method:

We treated with fluoxetine 235 outpatients meeting DSM-IV criteria for major depression. We measured T₃ resin uptake (T₃-RU) levels before the onset of treatment. The 17-item Hamilton Rating Scale for Depression (Ham-D-17) was administered before, during and after the eight weeks of treatment to assess changes in depressive symptoms.

Results:

16 patients (6.8 percent) had low T₃-RU levels (range 16.5–21), and 7 patients (3.0 percent) had high T₃-RU levels (range 36–38). No relationship was found between T₃-RU levels and clinical improvement, defined as either total Ham-D-17 score change or Ham-D-17 score ≤ 7 in the last 3 weeks of treatment, even after adjusting for baseline severity of depression.

Conclusion:

Abnormal T₃-RU levels are rather uncommon in outpatient depression and do not correlate with the response to antidepressant treatment or lack thereof.